中商官网
研究报告
石四药集团（HK2005）
| 科目\年度 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 现金及现金等价物净增加额 |
-32614.90 | -1901.80 | 14045.90 | 17523.20 | 55852.60 | -6574.70 | 25426.70 | 20616.20 | 12754.90 | 2178.10 | -1056.90 | -8269.30 | 15384.30 |
| 经营活动现金流量净额 |
49103.10 | 92574.70 | 73368.90 | 69562.59 | 50455.90 | 64595.70 | 96982.50 | 55243.80 | 68648.40 | 56269.40 | 30760.70 | 59792.20 | 24206.80 |
| 投资活动现金流量净额 |
-52176.00 | -64019.40 | -40272.40 | -65652.40 | -31238.60 | -72623.30 | -75534.50 | -37357.90 | -28484.60 | -26485.50 | -39640.50 | -88259.59 | -39406.10 |
| 融资活动现金流量净额 |
-29542.00 | -30457.10 | -19050.60 | 13613.00 | 36635.30 | 1452.90 | 3978.70 | 2730.30 | -27408.90 | -27605.80 | 7822.90 | 20198.10 | 30583.60 |
| 现金及现金等价物期末余额 |
125770.20 | 161520.80 | 166754.70 | 166173.60 | 144590.50 | 81742.90 | 90206.20 | 68731.90 | 44703.60 | 33896.40 | 32522.40 | 33692.80 | 41178.30 |
| 经营活动现金流量净额 |
49103.10 | 92574.70 | 73368.90 | 69562.59 | 50455.90 | 64595.70 | 96982.50 | 55243.80 | 68648.40 | 56269.40 | 30760.70 | 59792.20 | 24206.80 |
| 折旧与摊销 |
45565.10 | 40557.40 | 35889.30 | 37899.60 | 30398.40 | 27455.00 | 28204.20 | 25550.30 | 24409.60 | 21618.60 | 19278.30 | 14530.40 | 15154.20 |
| 营运资金变动 |
-92700.40 | -75289.99 | -75934.30 | -51506.90 | -33502.50 | -64199.30 | -24040.60 | -38415.10 | -7646.20 | -7178.80 | -35817.40 | 3409.40 | -23639.70 |
| 投资活动现金流量净额 |
-52176.00 | -64019.40 | -40272.40 | -65652.40 | -31238.60 | -72623.30 | -75534.50 | -37357.90 | -28484.60 | -26485.50 | -39640.50 | -88259.59 | -39406.10 |
| 资本性支出 |
54042.50 | 70387.09 | 41812.30 | 38832.30 | 32152.40 | 83600.00 | 58028.20 | 37323.60 | 32275.00 | 42992.70 | 85296.00 | 90968.80 | 41060.50 |
| 投资购买 |
-4598.50 | -- | -1241.50 | -2400.10 | -- | -- | -- | -- | -- | -- | -4494.30 | -7275.00 | -9768.80 |
| 融资活动现金流量净额 |
-29542.00 | -30457.10 | -19050.60 | 13613.00 | 36635.30 | 1452.90 | 3978.70 | 2730.30 | -27408.90 | -27605.80 | 7822.90 | 20198.10 | 30583.60 |
| 股份回购 |
-4456.30 | -3296.90 | -8615.80 | -18761.40 | -9886.20 | -1015.20 | -- | -2590.30 | -3153.20 | -54152.30 | -3483.80 | -- | -- |
| 支付股息 |
-56645.20 | -44741.00 | -39059.30 | -30555.00 | -33286.00 | -30240.20 | -24112.20 | -17067.90 | -7111.50 | -58105.00 | -23617.10 | -11719.80 | -10374.70 |
| 股票发行 |
-- | -- | -- | -- | 8256.00 | 5160.00 | 32388.80 | 6857.20 | 2970.00 | -- | 7120.00 | -- | -- |
| 现金及现金等价物净增加额 |
-32614.90 | -1901.80 | 14045.90 | 17523.20 | 55852.60 | -6574.70 | 25426.70 | 20616.20 | 12754.90 | 2178.10 | -1056.90 | -8269.30 | 15384.30 |
| 加：现金及现金等价物期初余额 |
161520.80 | 166754.70 | 166173.60 | 144590.50 | 81742.90 | 90206.20 | 68731.90 | 44703.60 | 33896.40 | 32522.40 | 33692.80 | 41178.30 | 25798.00 |
| 汇率变动对现金及现金等价物的影响 |
-3135.70 | -3332.10 | -13464.80 | 4059.90 | 6995.00 | -1888.60 | -3952.40 | 3412.10 | -1947.70 | -804.10 | -113.50 | 783.80 | -4.00 |
| 现金及现金等价物期末余额 |
125770.20 | 161520.80 | 166754.70 | 166173.60 | 144590.50 | 81742.90 | 90206.20 | 68731.90 | 44703.60 | 33896.40 | 32522.40 | 33692.80 | 41178.30 |